MANU Intrinsic Value

Intrinsic Value of MANU Overview

Key Highlights:
As of Mar 11, 2025 MANU Relative Value is $11.8, which is overvalued by 14.3%, compared to current share price of $13.8.
As of Mar 11, 2025 MANU DCF Value is N/A, which is undervalued by N/A, compared to current share price of $13.8.
Methodology
Price per share, $
Current share price
13.8
DCF value
not available

MANU Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

MANU Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
3.9x (as of Mar 11, 2025)
EV/Gross Profit
4.1x (as of Mar 11, 2025)
EV/EBIT
(23.7x) (as of Mar 11, 2025)
EV/EBITDA
30.3x (as of Mar 11, 2025)
EV/FCF
(17.6x) (as of Mar 11, 2025)
EV/OCF
40.0x (as of Mar 11, 2025)
P/Revenue
2.9x (as of Mar 11, 2025)
P/Gross Profit
3.0x (as of Mar 11, 2025)
P/EBIT
(17.5x) (as of Mar 11, 2025)
P/EBITDA
22.3x (as of Mar 11, 2025)
P/FCF
(12.9x) (as of Mar 11, 2025)
P/OCF
29.4x (as of Mar 11, 2025)
P/E
(13.3x) (as of Mar 11, 2025)
P/BV
9.1x (as of Mar 11, 2025)
PEG 1Y
4.0x (as of Mar 11, 2025)

MANU DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Jun'20 ActualJun'21 ActualJun'22 ActualJun'23 ActualJun'24 ActualJun'25 EstimateJun'26 EstimateJun'27 EstimateJun'28 EstimateJun'29 EstimateJun'30 EstimateJun'31 EstimateJun'32 EstimateJun'33 EstimateJun'34 EstimateJun'35 Terminal
% growth
509.0
(18.8%)
494.1
(2.9%)
583.2
18.0%
648.4
11.2%
661.8
2.1%
854.2
29.1%
889.7
4.2%
926.1
4.1%
974.2
5.2%
1,021.1
4.8%
1,066.3
4.4%
1,109.4
4.0%
1,149.9
3.7%
1,187.5
3.3%
1,221.8
2.9%
1,252.3
2.5%
5.2
1.0%
(36.9)
(7.5%)
(87.4)
(15.0%)
(11.2)
(1.7%)
(69.4)
(10.5%)
(67.4)
(7.9%)
(70.2)
(7.9%)
(73.1)
(7.9%)
(76.8)
(7.9%)
(80.5)
(7.9%)
(84.1)
(7.9%)
(87.5)
(7.9%)
(90.7)
(7.9%)
(93.7)
(7.9%)
(96.4)
(7.9%)
(98.8)
(7.9%)
NOPAT
% effective tax rate
5.8
1.1%
(141.7)
(28.7%)
(67.5)
(11.6%)
(9.8)
(1.5%)
(60.0)
(9.1%)
(58.3)
(6.8%)
(60.7)
(6.8%)
(63.2)
(6.8%)
(66.5)
(6.8%)
(69.7)
(6.8%)
(72.8)
(6.8%)
(75.7)
(6.8%)
(78.5)
(6.8%)
(81.1)
(6.8%)
(83.4)
(6.8%)
(85.5)
(6.8%)
% of revenue
141.5
27.8%
139.4
28.2%
165.8
28.4%
186.5
28.8%
206.6
31.2%
251.8
29.5%
262.2
29.5%
273.0
29.5%
287.1
29.5%
301.0
29.5%
314.3
29.5%
327.0
29.5%
338.9
29.5%
350.0
29.5%
360.1
29.5%
369.1
29.5%
% of revenue
(241.9)
(47.5%)
(144.4)
(29.2%)
(123.7)
(21.2%)
(171.8)
(26.5%)
(208.2)
(31.5%)
(225.4)
(26.4%)
(234.8)
(26.4%)
(244.4)
(26.4%)
(257.1)
(26.4%)
(269.5)
(26.4%)
(281.4)
(26.4%)
(292.8)
(26.4%)
(303.5)
(26.4%)
(313.4)
(26.4%)
(322.4)
(26.4%)
(330.5)
(26.4%)
(126.7)
(24.9%)
37.5
7.6%
65.7
11.3%
(31.1)
(4.8%)
14.7
2.2%
24.7
2.9%
25.8
2.9%
26.8
2.9%
28.2
2.9%
29.6
2.9%
30.9
2.9%
32.1
2.9%
33.3
2.9%
34.4
2.9%
35.4
2.9%
36.3
2.9%
Free Cash Flow to Firm (FCFF)
% of revenue
(221.3)
(43.5%)
(109.3)
(22.1%)
40.2
6.9%
(26.2)
(4.0%)
(46.9)
(7.1%)
(7.3)
(0.9%)
(7.6)
(0.9%)
(7.9)
(0.9%)
(8.3)
(0.9%)
(8.7)
(0.9%)
(9.1)
(0.9%)
(9.4)
(0.9%)
(9.8)
(0.9%)
(10.1)
(0.9%)
(10.4)
(0.9%)
(10.7)
(0.9%)
% of FCFF used in calculation
Discount period
Discount factor
Discounted FCFF (DFCFF)

MANU DCF Value

Crunching data... Almost there!

MANU Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

MANU Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
2.5%
FX rate
1.3
Last share price
17.4
Implied FCF growth 1-10Y
0.0%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with MANU Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$2,318.0M
$3,152.5M
$11.9
13.2% overvalued
N/A
$11.9
13.2% overvalued
Negative
123.0% overvalued
Negative
105.6% overvalued
N/A
N/A
0.0%
0.0%
$381.8B
$387.8B
$891.5
0.4% overvalued
$1,171.7
31.0% undervalued
$611.3
31.7% overvalued
$510.5
43.0% overvalued
$459.8
48.6% overvalued
22.1%
77.9%
22.4%
21.8%
$178.5B
$218.3B
$65.9
32.7% overvalued
$24.8
75.0% overvalued
$107.0
9.3% undervalued
$288.2
194.4% undervalued
$157.5
60.9% undervalued
47.9%
52.1%
7.8%
7.8%
$48.2B
$51.6B
$7.1
78.8% overvalued
$1.7
95.0% overvalued
$12.5
62.6% overvalued
$92.2
175.6% undervalued
$32.6
2.4% overvalued
38.1%
61.9%
23.3%
24.7%
$28.0B
($3,971.0B)
$11.4K
9,245.4% undervalued
N/A
$11.4K
9,245.4% undervalued
Negative
119.1% overvalued
Negative
109.5% overvalued
44.0%
56.0%
9.2%
13.9%
$25.4B
$22.8B
$43.1
316.1% undervalued
N/A
$43.1
316.1% undervalued
Negative
103.5% overvalued
$381.2
3,576.1% undervalued
(365.9%)
465.9%
(23.7%)
(27.1%)
$20.7B
$21.0B
$47.7
43.7% overvalued
$56.4
34.0% overvalued
$39.1
53.9% overvalued
$10.6K
12,410.6% undervalued
N/A
(26.9%)
126.9%
14.0%
14.8%
$15.4B
$16.2B
$20.3
34.0% overvalued
$8.2
73.0% overvalued
$32.4
5.3% undervalued
$87.1
183.3% undervalued
$50.4
63.7% undervalued
46.1%
53.9%
6.4%
6.4%
$11.7B
$14.2B
$160.5
10.6% undervalued
$174.0
20.0% undervalued
$147.0
1.3% undervalued
$1,084.9
647.4% undervalued
$64.7
55.4% overvalued
15.2%
84.8%
3.0%
1.9%
$10.2B
$8,579.1M
$44.3
36.4% overvalued
N/A
$44.3
36.4% overvalued
$46.8
32.8% overvalued
N/A
(22.1%)
122.1%
22.2%
20.4%

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.